These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 27809873)

  • 1. LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner.
    Wang WT; Ye H; Wei PP; Han BW; He B; Chen ZH; Chen YQ
    J Hematol Oncol; 2016 Nov; 9(1):117. PubMed ID: 27809873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes.
    Han BW; Ye H; Wei PP; He B; Han C; Chen ZH; Chen YQ; Wang WT
    BMC Genomics; 2018 Oct; 19(1):735. PubMed ID: 30305026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.
    Li J; Guan C; Hu Z; Liu L; Su Z; Kang P; Jiang X; Cui Y
    Hum Cell; 2021 Jan; 34(1):187-200. PubMed ID: 33040228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.
    Xu Y; Wang Z; Jiang X; Cui Y
    Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
    Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH
    Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axis.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Transl Res; 2020 Oct; 224():26-39. PubMed ID: 32505707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma.
    Song W; Miao DL; Chen L
    Biochem Biophys Res Commun; 2018 Dec; 506(4):1004-1012. PubMed ID: 30404735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
    Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y
    Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide identification of a competing endogenous RNA network in cholangiocarcinoma.
    Li G; Liu T; Zhang B; Chen W; Ding Z
    J Cell Biochem; 2019 Nov; 120(11):18995-19003. PubMed ID: 31270845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
    Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
    J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.
    Lin KY; Ye H; Han BW; Wang WT; Wei PP; He B; Li XJ; Chen YQ
    Oncogene; 2016 Jun; 35(26):3376-86. PubMed ID: 26455324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA LOXL1-AS1 acts as a ceRNA for miR-324-3p to contribute to cholangiocarcinoma progression via modulation of ATP-binding cassette transporter A1.
    Zhang B; Zhou M; Zou L; Miao J; Wang Y; Li Y; Lu S; Yu J
    Biochem Biophys Res Commun; 2019 Jun; 513(4):827-833. PubMed ID: 31003776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA H19 promotes vascular remodeling by sponging let-7a to upregulate the expression of cyclin D1.
    Sun W; Lv J; Duan L; Lin R; Li Y; Li S; Fu C; Zhao L; Xin S
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1038-1042. PubMed ID: 30551879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA LINC01061 sponges miR-612 to regulate the oncogenic role of SEMA4D in cholangiocarcinoma.
    Yu A; Zhao L; Kang Q; Chen K; Li J; Fu H; Liu J; Zhang X
    Biochem Biophys Res Commun; 2019 May; 513(2):465-471. PubMed ID: 30967271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
    Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
    Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.
    Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y
    Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA H19 Regulates Human Lens Epithelial Cells Function.
    Liu X; Liu C; Shan K; Zhang S; Lu Y; Yan B; Luo Y
    Cell Physiol Biochem; 2018; 50(1):246-260. PubMed ID: 30286462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H19 Functions as a Competing Endogenous RNA to Regulate EMT by Sponging miR-130a-3p in Glioma.
    Hu Q; Yin J; Zeng A; Jin X; Zhang Z; Yan W; You Y
    Cell Physiol Biochem; 2018; 50(1):233-245. PubMed ID: 30282068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo.
    Yao Y; Sun Y; Jiang Y; Qu L; Xu Y
    Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.